Suchergebnisse - "Corrales, Luis"

PubPharm (79)

1

The role of angiogenesis inhibitors associated with tyrosine kinase inhibitors in the first-line treatment for EGFR-mutated advanced lung cancer

enthalten in: Critical reviews in oncology/hematology | 2024

von Motta-Guerrero, R. | Recondo, G. | Cardona, A. | +4

2

Genomic ancestry and cancer among Latin Americans

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Ruíz-Patiño, A. | Rojas, L. | Zuluaga, J. | +8

3

Taxanes for the treatment of breast cancer during pregnancy : an international cohort study

enthalten in: Journal of the National Cancer Institute | 2024

von Ferrigno Guajardo, A. | Vaca-Cartagena, B. | Mayer, E. | +25

CommentIn: J Natl Cancer Inst. 2023 Dec 29;:. - PMID 38156705

4

Impact of Concurrent Genomic Alterations on Clinical Outcomes in Patients With ALK-Rearranged NSCLC

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Lara-Mejía, L. | Cardona, A. | Mas, L. | +12

5

Shifts in bacterioplankton community structure between dry and wet seasons in a tropical estuary strongly affected by riverine discharge

enthalten in: The Science of the total environment | 2023

von Marín-Vindas, C. | Sebastián, M. | Ruiz-González, C. | +3

6

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050) : a randomised, open-label, multicentre, phase 3 trial

enthalten in: Lancet (London, England) | 2023

von Qin, S. | Chen, M. | Cheng, A. | +122

CommentIn: Lancet. 2023 Nov 18;402(10415):1806-1807. - PMID 37883983

7

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859) : a multicentre, randomised, double-blind, phase 3 trial

enthalten in: The Lancet. Oncology | 2023

von Rha, S. | Oh, D. | Yañez, P. | +121

8

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) : Results of an Observational Longitudinal Cohort Study

enthalten in: Targeted oncology | 2023

von Chamorro, D. | Cardona, A. | Rodríguez, J. | +35

9

High-Dose vs. Low-Dose Dexamethasone in Patients With COVID-19 : A Cohort Study in Rural Central America

enthalten in: Journal of acute medicine | 2023

von Montalvan-Sanchez, E. | Chambergo-Michilot, D. | Rodriguez-Murillo, A. | +13

10

Perilesional edema diameter associated with brain metastases as a predictive factor of response to radiotherapy in non-small cell lung cancer

enthalten in: Frontiers in oncology | 2023

von Arrieta, O. | Bolaño-Guerra, L. | Caballé-Pérez, E. | +12

1
2
3
4
5
6
7
8
Nächster »
[8]